Nothing Special   »   [go: up one dir, main page]

Sun et al., 2016 - Google Patents

GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing

Sun et al., 2016

View HTML
Document ID
14893750216927126671
Author
Sun L
Jin H
Li H
Publication year
Publication venue
Oncotarget

External Links

Snippet

There are many molecules that define regulatory T cells (Tregs) phenotypically and functionally. Glycoprotein A repetitions predominant (GARP) is a transmembrane protein containing leucine rich repeats. Recently, GARP is found to express highly on the surface of …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes

Similar Documents

Publication Publication Date Title
Sun et al. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing
Zhang et al. CD58 Immunobiology at a Glance
Lin et al. Heterogeneity of HLA-G expression in cancers: facing the challenges
Moreau et al. Transforming growth factor–β1 in regulatory T cell biology
López-Larrea et al. The NKG2D receptor: sensing stressed cells
Wu et al. Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells
Wang et al. Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3
Le Mercier et al. Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
López‐Soto et al. NKG2D signaling in cancer immunosurveillance
Zhang et al. NKG2D ligands in tumor immunity: two sides of a coin
Bonini et al. Adoptive T‐cell therapy for cancer: The era of engineered T cells
Siemaszko et al. NKG2D natural killer cell receptor—a short description and potential clinical applications
Dunn et al. Cancer immunoediting in malignant glioma
Poschke et al. Camouflage and sabotage: tumor escape from the immune system
Wu et al. γδ T cells and their potential for immunotherapy
Leung et al. The CD28-B7 family in anti-tumor immunity: emerging concepts in cancer immunotherapy
Wang et al. Implications of NKG2A in immunity and immune-mediated diseases
Diefenbach et al. Strategies for target cell recognition by natural killer cells
Hayakawa et al. NKG2D and cytotoxic effector function in tumor immune surveillance
Hong et al. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use
EP3730609A1 (en) Cell
Moatti et al. The TNF-α/TNFR2 pathway: targeting a brake to release the anti-tumor immune response
Jin et al. Mechanism of T cell exhaustion in a chronic environment
Qian et al. Myeloid checkpoints for cancer immunotherapy
Hwang et al. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects